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Abstract
Traumatic brain injuries (TBI) are among the leading causes of death and chronic dis-
ability worldwide. TBI is a complex process encompassing primary injury to the brain 
tissue and cerebral vasculature induced by the initial impact, secondary injury, including 
cascade of subsequent neuroinflammatory processes, and regenerative responses with 
enhanced neurogenesis and angiogenesis. To date, there remains no approved pharma-
cological therapy that is able to prevent the secondary injury. Therefore, the develop-
ment of safe and efficacious neuroprotective treatments currently represents the greatest 
unmet need in the management of TBI. Increasing number of experimental and clini-
cal studies present convincing evidence that hyperbaric oxygen therapy (HBOT), as an 
adjunctive therapy, may be the suitable neurotherapeutic method for improving neuro-
logical outcome after TBI. Irrespective to treatment protocol HBOT appeared to allevi-
ate the detrimental and neurotoxic effects of pathological sequel initiated by TBI and to 
stimulate endogenous reparative mechanisms. However, the exact mechanisms by which 
HBOT exerts its beneficial effects on recovery after brain injury are still deficient. In this 
review we will summarize up to date results of HBOT in experimental and clinical TBI 
and try to put more light on cellular and molecular mechanisms underlying beneficial 
effects of HBOT on functional recovery after brain injury.
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1. Introduction
Traumatic brain injuries (TBI) are one of the leading causes of death and chronic disability 
especially among the working population, and represent an important public health problem 
worldwide. Globally, about 10 million people are affected by TBI every year with projections 
that TBI will be one of the major causes of death and disability by the year 2020 [1]. Since TBI 
is a complex injury that encompasses a broad spectrum of symptoms and disabilities, the 
manifestations of head injury may be clinically very variable ranging from mild, to moder-
ate or severe, depending on the extent and duration of damage to the brain. Many cognitive, 
physical and psychological skills can be affected, exerting a devastating impact on the patients 
and their family [2]. Over the years more than 30 phase III clinical trials failed emphasizing 
the urgent need for efficient treatment modalities and new directions in the future research to 
improve posttraumatic morbidity and mortality. Considering the complexity of TBI it is rea-
sonable to assume that only combination of different treatment protocols could provide better 
prognosis for recovery to all forms of TBI [3]. In this view, hyperbaric oxygenation (HBO) or 
hyperbaric oxygen therapy (HBOT) appeared as an adjunctive therapy that may have the 
synergistic effect with other treatment protocols, suggesting that combining therapies with 
HBOT could provide better results than either alone [4]. According to definition given by 
the Undersea and Hyperbaric Medical Society (UHMS), hyperbaric medicine is a therapeutic 
approach in which a patient breathes 100% oxygen intermittently, while the pressure of the 
treatment chamber is higher than ambient (1 atmosphere absolute, 1 ATA = 101.3 kPa) [5–7]. In 
comparison to the normobaric conditions increased oxygen supply under hyperbaric condi-
tions enables easier diffusion of oxygen into the injured tissue [8]. Accordingly, the HBOT can 
be used to obtain 100% saturation of hemoglobin and to significantly elevate the volume of 
physically dissolved oxygen fraction in blood plasma. This increased blood oxygen level then 
can penetrate to ischemic areas and perilesioned tissue more deeply than under normobaric 
conditions [9–11]. Thus, the HBOT has found its place, as the primary or adjuvant therapy in 
the treatment protocols for different clinical conditions [12, 13].
On the other hand, opinions about usage of HBOT as adjunctive therapy for the treatment 
of patients with brain injuries are still controversial [14–16]. In this way HBO is a very moti-
vating therapeutic modality, which is known to produce oxidative stress by itself [17], but 
reduces oxidative stress when used in pathological conditions [18, 19]. The main concern in 
HBOT is oxidative stress and/or oxygen toxicity that can affect multiple organs. However, 
these side-effects are dependent on treatment parameters – pressure and duration of the 
treatment [20–23].
Substantial amount of evidences has been published indicating that HBOT can interfere 
with the processes that are following brain injury and moderate its consequences [14, 24–27]. 
Recent results of experimental and clinical studies and potential mechanisms of HBOT in TBI 
are reviewed by Wang et al. [28] and Hu et al. [7]. However, knowledge about the exact mech-
anisms by which HBOT exerts its beneficial effects is still deficient. Therefore, data presented 
in this chapter are meant to put more light on cellular and molecular mechanisms underlying 
neuroprotective effects of hyperbaric oxygenation after the brain injury.
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2. Potential cellular and molecular mechanisms underlying HBOT
Increasing number of animal studies on HBOT in experimental TBI revealed a myriad of 
diverse mechanisms that may underlie neuroprotective effects of HBOT. Researchers sug-
gested that many of these cellular and molecular mechanisms and signaling pathways work 
in parallel, or together, contributing to repair of the injured brain [6, 7, 23, 25, 28]. These mech-
anisms involve: (1) alleviation of secondary injury; (2) increasing of tissue oxygenation; (3) 
reducing of neurodegeneration; (4) decreasing of apoptosis; (5) regulation of oxidant/antioxi-
dant status; (6) reduction of oxidative stress; (7) attenuation of reactive gliosis (microgliosis 
and astrogliosis) and glial scarring; (8) reducing of inflammation; (9) enhancement of neuronal 
plasticity; (10) promoting of synaptogenesis, neurogenesis and angiogenesis.
2.1. HBOT suppresses development of secondary brain damage
TBI involves primary and secondary injury. Primary injury occurs at the time of the impact and 
is the result of immediate mechanical damage of neural pathways followed by a permanent 
neuronal lost. The site of mechanical impact is called the “core”. Surrounding regions consist 
of neuronal tissue that have not been directly affected by trauma and are often addressed to 
as “penumbra area”. Neurons inside this zone are at risk due to a cascade of events, known 
as secondary injury that involves: impaired blood flow (limited or not at all), inflammation, 
development of edema, acidosis and hemorrhage, and the loss of most of their connections with 
the other neurons [11, 21, 22]. Secondary degeneration can also progress into the surround-
ing intact regions of the brain. Compromised blood flow and insufficient oxygen supply leads 
to tissue hypoxia and the resulting energy failure, which initiates a cascade of cellular events 
that culminate with neuronal cell apoptosis [23]. Thus, the consequence of secondary injury 
is degeneration of neurons that previously have not been exposed to trauma [29–31]. Most 
of the neurotherapeutic strategies are directed toward the containment of the secondary pro-
cesses and the preservation and reactivation of the penumbra area and perilesioned region [30]. 
Cumulative evidence have proved that HBOT may reduce development of secondary brain dam-
age and prevent neuronal apoptosis in animal models of TBI [32, 25], ischemic stroke [33–37], 
and hypoxia-ischemia [38–40], which was manifested by diminishing of brain infarction area and 
improvement of neurological deficits. Recently, Baratz-Goldstein et al. [41] demonstrated that 
both immediate (initiated 3 h post-injury) and delayed treatments with HBO (initiated 7 days 
post-injury) have a potential to prevent a neuronal loss in mouse model of moderate TBI.
2.2. HBOT reduces neuronal degeneration and prevents apoptosis after brain injury 
by regulation of oxidant/antioxidant status and reduction of oxidative stress
One of the main processes in this pathological cascade is oxidative stress that develops in the cells 
which have been exposed to trauma and in the cells at “penumbra area”. Reactive oxygen spe-
cies (ROS) are one of the products of oxidative stress [2] that are responsible for cellular damag-
ing and apoptosis. The first line of the defense against ROS are enzymes located in mitochondria, 
such as manganese superoxide dismutase (SOD2) [42]. In our previous study, we have shown 
that repetitive HBOT influenced the pattern of SOD2 expression both on gene and protein level in 
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cortical stab injury model (CSI) of TBI [43]. We applied HBO protocol of 60 min exposure to 100% 
oxygen at 2.5 ATA, once a day for 3 or 10 consecutive days. HBOT significantly increased mRNA 
levels of SOD2 at both time points compared to the corresponding lesioned group. Exposure to 
HBOT for 3 days down-regulated SOD2 protein levels in the injured cortex, while after 10 days 
of HBOT an up-regulation of SOD2 was observed. Using double-immunofluorescence staining 
we have demonstrated that HBOT attenuated SOD2 expression both in neuronal and astroglial 
cells surrounding the lesion site. Staining of the injured cortex with Fluoro-Jade®B (as a marker 
of degenerating neurons) revealed that HBOT significantly decreased the number of degener-
ating neurons in the injured cortex, and this effect was more pronounced after 10 consecutive 
HBOT. In according to this, we concluded that antioxidative and neuroprotective effect of HBOT 
is in part due to its influence on expression pattern of SOD2 [43].
In this chapter, using the cortical suction ablation (CSA) model of brain injury, described in 
our previous publications [44, 45], and the same HBOT protocol, we demonstrated that 10 
repetitive HBOT altered activities of antioxidant enzymes and reduced lipid peroxidation, 
thereby preventing neuronal degeneration and apoptosis. Oxidant/antioxidant status in the 
injured cortex after HBOT is presented in Figure 1. HBOT significantly increased glutathione-
peroxidase (GPX) activity in the injured cortex compared to all other groups. Injury markedly 
lowered the level of superoxide dismutase (SOD) activity, while HBOT returned SOD activity 
to almost control levels. The content of Malondialdehyde (MDA), which was used as an indi-
cator of lipid peroxidation and reflects the membrane damage caused by ROS, was the highest 
in the tissue samples from injured cortex. HBOT initiated statistically significant reduction of 
MDA levels, pointing to preservation of membrane integrity. The similar trend of changes of 
MDA levels was determined in the serum indicating that serum concentrations of MDA may 
be used as a marker of degree of brain damage.
To evaluate the effect of HBOT on neurodegeneration/apoptosis we performed double-
immunofluorescence staining: neurons undergoing degeneration were visualized with 
Fluoro-Jade®B, while NeuN (neuronal cell nuclei) was used as a marker of neuronal cell 
bodies. As it is shown in Figure 2, in the perilesioned cortex a huge number of neurons under-
going degeneration (Figure 2A, E) was significantly reduced after the HBOT (Figure 2B, F). 
Moreover, when the cortical sections from the injured (L) group were observed at higher 
magnification the formation of apoptotic bodies (Figure 2G, I, asterisks) in the neuronal 
nuclei was observed, indicating that they have entered into the process of apoptosis. On the 
contrary, in the sections from LHBO group the majority of neurons have healthy nuclei in 
which the nucleolus was clearly visible (Figure 2H, J, arrow heads). These results indicate 
that increased activities of antioxidant enzymes and reduction of lipid peroxidation underlies 
observed neuroprotective and anti-apoptotic effects of HBOT. Similarly, Li et al. [51], in the 
rat model of brain ischemia-reperfusion injury (IRI), have shown that HBO preconditioning 
lessened neuronal injury, reduced the level of MDA and increased the antioxidant activity 
of catalase (CAT) and SOD. They suggested that an up-regulation of the antioxidant enzyme 
activities after HBO preconditioning may play an important role in the generation of toler-
ance against IRI.
Maintaining proper mitochondrial function is essential for cellular function, since ROS are 
formed in mitochondria when energy metabolism is compromised. Niizuma and co-workers 
[52] demonstrated that mitochondrial dysfunction and oxidative stress may determine neuronal 
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death/survival after stroke and neurodegeneration. Therefore, a lot of studies have been 
conducting with purpose of finding out whether HBOT have a role in the preservation of 
mitochondrial function and integrity [25, 32, 53–55]. Palzur, Vlodavsky and their colleagues, 
Figure 1. Effects of HBOT and cortical injury on the activities of antioxidant enzymes and lipid peroxidation in the injured 
cortex. Glutathione-peroxidase (GPX) activity is measured using coupled enzyme method by measuring the decrease of 
NADPH at 340 nm [46] and is expressed as unites per milligram of protein (U/mg). One unit (U) catalyzes the oxidation by 
H
2
O
2
 of 1.0 μmol of reduced glutathione to oxidized glutathione per minute. Total superoxide dismutase (SOD) activity is 
determined at room temperature according to the method of Misra and Fridovich [47], and is measured at 480 nm. One unit of 
SOD is defined as the amount of enzyme that inhibits the speed of oxidation of epinephrine for 50%. The results are expressed 
as U/mg of protein. Malondialdehyde (MDA) content is determined both in the injured cortex and serum. Thiobarbituric acid 
(TBA) reactive product MDA is used as an indicator of lipid peroxidation. MDA content is measured according to the method 
of Aruoma et al. [48] as described previously in Mladenovic et al. [49]. The absorbance of the organic phase is read at 532 nm. 
The values are expressed as nmol of MDA/mg of protein, using a standard curve of 1,1,3,3-tetramethoxypropane. Total protein 
was quantified according to Lowry’s method [50] using bovine serum albumin as standard. Values are mean ± SD from n ≥ 4 
independent determinations performed in duplicate. Acronyms for the groups (n = 8 per group) are as follows: C – intact 
control, CHBO intact control subjected to the HBO protocol, S – sham surgery, SHBO sham control HBO group, L - injured 
group and LHBO - injured group subjected to the HBO protocol. Significant difference from corresponding group * P < 0.05 
vs. L, # P < 0.05 vs. C, † P < 0.05 vs. CHBO, ‡ P < 0.05 vs. S, § P < 0.05 vs. SHBO.
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Figure 2. HBOT reduces neurodegeneration and prevents apoptosis in the injured cortex. Fluoro-jade®B staining (green) 
is performed in order to visualize neuronal cells undergoing degeneration and cell death, while NeuN (red) is used as a 
marker of neuronal cell bodies. Procedure for double-immunofluorescence staining was as described in Parabucki et al. 
[43]. Cortical sections were incubated with mouse anti-NeuN (1:200, Milipore, USA) and then with 0.0004% solution of 
Fluoro-Jade®B (FJB, Chemicon International, Temecula, CA, USA) dissolved in 0.1% acetic acid. The slides were examined 
with Carl Zeiss AxioVert microscope with AxioCam monochromatic camera (Zeiss, Goettingen, Germany), equipped 
with ApoTome software for optical sectioning. (A, C, E) A huge number of NeuN+ neurons in the perilesioned cortex were 
co-stained with FJB (A, yellow fluorescence) indicating that they are undergoing neurodegeneration. Strikingly, when the 
cortical sections from the injured (L) group were observed at higher magnification, the formation of apoptotic bodies (G, 
I, asterisks) in the neuronal nuclei was observed, suggesting that they have entered into the process of apoptosis. (B, D, 
F) after 10 repetitive HBOT the number of NeuN+/FJB+ (B) and FJB+ (F) neurons was negligible. Correspondingly, in the 
LHBO cortical sections the majority of neurons have healthy nuclei in which the nucleolus was clearly visible (H, J, arrow 
heads). Rectangles indicate where the high magnification images are taken from. Scale bars: (A-J) 50 μm.
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using cortical deformation model of TBI and the HBO protocol which consisted of two suc-
cessive 45 min sessions at 2.8 ATA, have shown that increased concentrations of oxygen in 
the cells lead to preservation of mitochondrial integrity due to significant decrease of the 
loss of mitochondrial trans-membrane potential. Additionally, HBOT reduced the release 
of pro-apoptotic mediators Cytochrome C (Cyt C) and the Bcl-2-associated X protein (Bax) 
from mitochondria, and up-regulated the expression of anti-apoptotic protein Bcl-2 (B-cell 
lymphoma 2), consequently alleviating neuronal apoptosis in the injured brain tissue [56]. 
Zhou et al. [57] have emphasized that maintenance of mitochondrial function is one of the 
most important effects of HBOT.
TBI leads to the impairment of cerebral oxygen delivery and consumption [58]. So, the main 
problem is how to make cerebral hyperoxia, which is possible either under normobaric 
(NBH) or hyperbaric conditions. Clinical trials have shown that hyperbaric O2 has better 
effect than NBH on oxidative cerebral metabolism due to its ability to produce a brain tissue 
PO2 > or = 200 mm Hg, which represents a graduated effect [14].
Oxidative stress, and/or oxygen toxicity as unwanted side-effects of HBOT, as well as the fact 
that inhalation of pure oxygen at high pressures may lead to generation of ROS led researches 
to investigate which anti-oxidants can be used during HBO therapy. Studies have shown that 
hydrogen gas (H2) could be useful for this purpose. It alleviates oxygen toxicity due to reduc-
tion of hydroxyl radical levels [59]. Even, adding of inert gases, such as argon or xenon during 
HBO treatments can potentially make further improvement of cerebral lesions [60].
2.3. HBOT attenuates reactive microgliosis, astrogliosis and glial scarring after brain 
injury
After the injury astrocytes become rapidly activated during the process of “reactive astroglio-
sis” and accumulate around the lesion site, acting as a barrier that impedes neuroregenera-
tion and neurite outgrowth, and isolates intact CNS tissue from secondary lesions [61, 62]. 
Proportionally to the severity of injury, they undergo cell proliferation, hypertrophy, increased 
expression of glial fibrillary acidic protein (GFAP) and vimentin, and exhibit an enhancement 
of immune-modulating capacities [2, 44, 63–66]. In our recently published paper [66] we have 
shown that repetitive HBOT attenuates reactive astrogliosis, prevent glial scar formation, and 
down-regulates GFAP and vimentin gene, protein and tissue expression in the perilesioned 
cortex. Similarly, Baratz-Goldstein et al. [41] demonstrated that both immediate and delayed 
HBOT have a potential to reduce reactive astrogliosis in mice model of TBI. Here, we reported 
that HBOT reduces reactive microgliosis around the lesion site as well (Figure 3B). Besides 
decreasing the number of activated microglia, HBOT also alters the morphology of activated 
microglia to more ramified, resting form (Figure 3B upper rectangle, D inset, F inset).
HBO-induced suppression of microgliosis and astrogliosis was reported to give an account to 
beneficial effects of HBO treatment in different rat models of TBI [41, 67, 68], cerebral ischemia 
[69], neuropathic and inflammatory pain [70, 71]. In contrast, Lee et al. [72] reported that pro-
longed HBOT may increase degree of gliosis indicating that longer oxygen cycling might help 
overcoming detrimental effects of gliosis and providing its beneficial effects.
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Figure 3. HBOT reduces reactive microgliosis in the perilesioned cortex and down-regulates ICAM-1 expression on 
microglial cells. (A) and (B) Effect of HBOT on reactive microgliosis in the injured cortex is determined using mouse 
anti-CD68 antibody (ED1, 1:100, Abcam, Cambridge, MA, USA) as a marker of activated microglia/macrophages. 
After using appropriate peroxidase linked secondary antibody (1:200, Santa Cruz Biotechnology, Santa Cruz, CA, 
USA), the products of immunoreactions were visualized with 3′3-diaminobenzidine (DAB, Dako, Glostrup, Denmark). 
Immunohistochemical and immunofluorescence staining was performed as described in Lavrnja et al. [66]. (A) after 
cortical injury a huge number of activated microglia/macrophages are seen around and within the lesion site. (B) HBOT 
(60 min exposure to 100% oxygen at 2.5 ATA) initiated daily for 10 consecutive days attenuated reactive microgliosis 
and alters morphology of activated microglia to more ramified, resting form (B, upper rectangle). (C–H) expression of 
ICAM-1 (green) on microglial cells stained with Iba1 (red) in cortices of injured (L) and injured group subjected to HBO 
protocol (LHBO) is visualized with immunofluorescence double-labeling. Cortical sections were incubated with goat 
anti-ICAM1 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and mouse anti-Iba1 (ionized calcium binding 
adaptor molecule 1, 1:500, Abcam, Cambridge, MA, USA) antibody, while nuclei were counterstained with DAPI 
(Invitrogen, Grand Island, NY, USA). All sections were photographed with Carl Zeiss Axiovert microscope with AxioCam 
monochromatic camera (Zeiss, Goettingen, Germany), equipped with ApoTome software for optical sectioning. (C, E, G) 
activated microglia characterized with round morphology showed up-regulation of ICAM-1 expression (G). (D, F, H) 
repetitive HBOT downregulated ICAM-1 expression on activated microglia within the lesion site. Microglial cells with 
ramified morphology (insets to D and F) do not express ICAM-1 (insets to D and H). Rectangles indicate where the high 
magnification images are taken from. Scale bars: (A, B) 50 μm (C–H) 5 μm.
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2.4. HBOT prevents spreading of the neuroinflammation in the injured tissue
Inflammation is an important part of the pathophysiology of TBI and has a pivotal role in 
the extent of neuronal injury and repair. It is postulated that the initiation, progression and 
resolution of inflammation in TBI is multifaceted. These processes involve migration, recruit-
ment and infiltration of leukocytes following blood-brain barrier (BBB) disruption and acti-
vation of resident immune cells of the CNS (microglia, astrocytes). Microglia and astrocytes 
then acquire immunological function and secrete inflammatory mediators such as pro- and 
anti-inflammatory cytokines, chemokines, adhesion molecules, complement factors, ROS and 
other factors [58, 73, 74]. The accumulation of neutrophils around the site of injury and their 
infiltration into the injured brain area is crucial for the initiation and progression of inflamma-
tion and the extent of secondary brain damage since they may release free oxygen and nitro-
gen radicals and pro-inflammatory cytokines [54, 58]. Neutrophils initially attach to vascular 
endothelium via binding to the endothelial intercellular adhesion molecules (ICAMs). In our 
previously mentioned paper [66] we have demonstrated injury-induced increase of gene and 
tissue expression of ICAM-1 (Intercellular Adhesion Molecule-1, CD54), an adhesion mol-
ecule that is important for trans-endothelial migration of neutrophils and propagation of 
inflammation [75, 76]. Using double- immunofluorescence staining we demonstrated its local-
ization on various type of cells (astrocytes, vascular endothelium, neurons, activated microg-
lia/macrophages and neutrophils), around the blood vessels, and in the proximity and within 
the lesion site. Ten successive treatments with HBO significantly decreased ICAM-1 mRNA 
expression returning it to control levels, while increased ICAM-1 immunoreactivity around 
the lesion site was diminished [66]. Herein, using double-immunofluorescence staining 
we have shown that HBOT reduced expression of ICAM-1 on activated microglia within the 
lesion site (Figure 3H). Furthermore, HBOT increased number of ramified/resting microglia 
in the perilesioned cortex (Figure 3B, upper rectangle). Interestingly, they do not express 
ICAM-1(Figure 3H, inset). These data indicate that HBOT by reducing ICAM-1 expression 
and targeting the passage of immune cells through the BBB via inhibition of cell adhesion 
molecules may contribute to dampen the neuroinflammatory response to TBI. Several studies 
also have shown that HBOT reduces the expression of ICAM-1 and adhesion of neutrophils to 
the endothelium, which is correlated with improved neurological outcome [54, 77–80].
CD40 ligand (CD40L, also termed CD154, or GP39) and its counter receptor CD40 (a membrane 
protein that belongs to the tumor necrosis factor (TNF) receptor family) are well-known regula-
tors of pro-inflammatory and immune responses in the CNS [81], and are members of CD40/
CD40L/ICAM-1 deleterious cascade of events after TBI. Given that CD40/CD40L dyad fosters 
neuroinflammation, it is suggested that CD40/CD40L interaction may be involved in modulat-
ing the outcome from injuries of the brain [82–84]. Accordingly, strategies aimed at suppressing 
CD40/CD40L/ICAM-1 expression may attenuate inflammation and neuronal damage after TBI, 
which will ultimately be of benefit in recovery [85]. In our recent paper [66] we have for the first 
time shown that HBOT prevents injury-induced up-regulation of expression of CD40 and its 
ligand CD40L on microglia/macrophages, neutrophils, cortical neurons and reactive astrocytes. 
These results indicate that repetitive HBOT, by limiting expression of inflammatory mediators, 
supports formation of more permissive environment for repair and regeneration.
Data of many studies has been shown that HBO suppress various mediators of inflammation 
[54, 67, 86, 87] indicating that the decreased brain edema, blood-brain barrier leakage, cell 
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apoptosis and improved neurological outcome are closely related to the inhibitory effect of 
HBOT on inflammation after TBI [7]. During the early stage of TBI, effect of HBOT in reducing 
inflammation was achieved by increasing anti-inflammatory cytokine interleukin-10 (IL-10) 
and transforming growth factor-β1 (TGF-β1) expression, decreasing of the RNA and protein 
levels of caspase-3, interleukin-8 (IL-8), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), 
macrophage inflammatory protein-2 (MIP-2), monocyte chemoattractant protein-1 (MCP-1) 
and transforming growth-interacting factor (TGIF), as well as via reduction of the expres-
sion of matrix metalloproteinase-9 (MMP9) [28, 54, 67, 68, 88–90]. Recently, Geng et al. [91] 
demonstrated that HBOT suppressed protein expression of inflammasome components and 
reduced the levels of interleukin-1β (IL-1β), interleukin-18 (IL-18) and high-mobility group 
box 1 (HMGB1) protein in the injured brain tissues and serum. Based on these results authors 
assumed that HBOT may diminish the inflammatory response after TBI by inhibiting the 
activation of inflammasome signaling. Latest results of Meng et al. [86] showed that HBOT 
significantly increased the expression of nuclear factor (erythroid-derived 2)- related factor 2 
(Nrf2) and heme oxygenase-1, and inhibited the expression of Toll-like receptor 4 and nuclear 
factor-kappa B in a rat TBI model [87]. Furthermore, HBOT decreases expression of nNOS, 
eNOS and iNOS (neuronal, endothelial and inducible nitric oxide synthases) mRNA in the 
cortex after acute traumatic cerebral injury [92].
2.5. HBOT improves neurofunctional recovery of the injured brain by enhancing 
neuronal plasticity and synaptogenesis
Growing number of studies have reported that, irrespective to diversity of protocols, HBO ther-
apy applied after TBI improved neurological status including motor and cognitive function, as 
well as learning and memory abilities, indicating that the best prognosis is achieved by earlier 
and continuous HBO treatment [11, 41, 45, 57, 67, 88, 93]. On the other hand, Baratz-Goldstein 
et al. [41] demonstrated that delayed treatment with HBO (initiated 7 days post-injury) also 
lead to improvement in learning abilities in mice model of moderate TBI. Additionally, in their 
recent publication Lim et al. [90] suggested that HBO treatment may ameliorate TBI-induced 
depression-like behavior in rats.
In our previously published paper [45] we have demonstrated that HBOT improves recov-
ery of locomotor performances and sensorimotor integration after cortical injury in rats by 
enhancing neuroplastic responses and promoting synaptogenesis. Using growth-associated 
protein 43 (GAP43) and synaptophysin (SYP) as markers of axonal sprouting and synapto-
genesis, respectively, we were the first to demonstrate that HBOT induces over-expression of 
GAP43 and SYP in the neurons surrounding the injury site. Given that an increase in GAP43 
and SYP expression occurs concomitantly with improvement of locomotor abilities, we sug-
gested that mechanisms underlying HBOT action involve promoting of axonal sprouting and 
the formation of new functional synaptic circuits. This implies that axonal reorganization 
and synapse remodeling contribute to observed functional recovery. Recent results of Zhang 
et al. [93] that HBOT-induced increase of GAP43 and synaptophysin expression underlies 
observed enhancement of learning abilities in the controlled cortical impact (CCI) model 
of rat brain injury confirmed our assumptions. Furthermore, Chen and Chen [94] detected 
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HBOT-induced enhancement of SYP expression after hypoxia-ischemia and proposed that 
the induction of synaptic plasticity and reducing of the ultrastructural damage may underlie 
rehabilitation mechanisms of HBOT.
2.6. HBOT promotes neurogenesis and angiogenesis after TBI
Nowadays, stem cells are in the center of attention. Stimulation of neurogenesis after HBOT 
and influence of stem cells mobilization on motor and cognitive performances is demonstrated 
in numerous studies [67, 95–97]. Thus, Shandley et al. [97] showed that cognitive improvement 
observed after treatment with HBO in patients with mild to moderate TBI is correlated with 
stem cell mobilization. Based on these findings they hypothesized that stem cells, mobilized by 
HBOT treatment, are recruited to repair damaged neuronal tissue. Yang et al. [98] and Wang 
et al. [99] reported that HBOT promotes the migration and differentiation of endogenous neu-
ral stem cells (NSCs) in neonatal rats with hypoxic-ischemic (HI) brain damage. Authors have 
shown that after HBOT, an increase in newly generated neurons, oligodendrocytes and remy-
elination was observed in the HI group treated with HBO compared to the untreated HI rats. 
Further, it was suggested that HBOT-stimulated proliferation of NSCs protects the learning 
and memory ability of the HI rats [100]. In our recent preliminary reports [101, 102] we also 
noticed that HBOT when applied after brain injury promoted endogenous NSCs to migrate to 
the site of injury and differentiate into mature neurons, contributing to improved neurofunc-
tional recovery of the injured brain. Moreover, we demonstrated that HBOT alters morphology 
of neuronal precursors to more matured morphology [102].
Mu et al. [103] suggested that activation of several signaling pathways and transcription fac-
tors (Wnt, hypoxia-inducible factors - HIFs, and cAMP response element-binding - CREB) 
play an important role in HBOT-induced neurogenesis. Furthermore, it was assumed that 
endogenous neurogenesis, enhanced by application of delayed HBO in the late-chronic phase 
of stroke, is possibly mediated by ROS/HIF-1α/β-catenin pathway [96].
Interestingly, combining of HBOT with bone marrow stem cells (BMSCs) transplantation 
showed synergistic effect and had favorable influence in improving rehabilitation after rat 
spinal cord injury [104]. The same combination of HBOT and BMSCs transplantation proved 
to be more effective for repair of cognitive and neurological functions after TBI than mono-
therapy [105]. Similarly, long course of HBO treatments (for 3 weeks) promote the mobiliza-
tion and migration of BMSCs to ischemic brain, stimulate expression of trophic factors and 
neurogenesis, and help in neuronal repair after ischemic stroke [72].
Besides neurogenesis HBOT may improve the outcome of TBI by stimulating angiogenesis 
[67, 95, 106, 107]. Using brain perfusion imaging, Tal et al. [106] demonstrated that 60 daily 
HBOT sessions stimulate cerebral angiogenesis in post-TBI patients, which induced signifi-
cant improvement in the global cognitive scores. These data strongly suggest that one of the 
ways in which HBOT can induce neuroplasticity is angiogenesis. Given that HBOT was initi-
ated 6 months to 27 years after the injury, obtained results imply that HBOT may improve 
perfusion to the chronic damaged brain tissue even months to years after the injury. Recent 
results of the same group [107] showed that in addition to the increased cerebral blood flow 
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and volume, HBOT improved both white and gray microstructures pointing to regeneration 
of nerve fibers. These micro structural changes correlate with the significant improvement in 
the memory, executive functions, information processing speed and global cognitive scores.
3. Conclusions
HBOT has been used as a primary or adjunctive therapy over the last 50 years, both in experi-
mental and clinical studies. However, despite the decades of extensive research the entire 
spectrum of HBOT action is still not completely understood, although many mechanisms of 
its action have been proposed. Therefore, in this systematic review we elaborate the cellular 
and molecular mechanisms of HBOT actions. Based on the presented data it may be concluded 
that improved tissue oxygenation and cellular metabolism, anti-inflammation, anti-apoptosis, 
as well as intensifying of neuroplastic responses, promoting of synaptogenesis, neurogenesis 
and angiogenesis may constitute the multiple and complementary mechanisms underlying 
HBOT-induced neuroprotection. In addition, reduction of lipid peroxidation and up-regula-
tion of antioxidant enzymes are among the mechanisms involved in the action of HBO. In that 
way, HBOT diminishes imbalance between oxidants and anti-oxidants that occurs after brain 
injury, and contributes to the maintenance of pro−/antioxidant homeostasis. Furthermore, 
HBOT effectively attenuates reactive astrogliosis and microgliosis, prevents tissue-damaging 
effects of neutrophils and suppresses formation of glial scar. Accordingly, by alleviating glia-
mediated inflammatory response and limiting production of inflammatory mediators HBOT 
fosters formation of more permissive environment for tissue repair, allowing the recovery 
of impaired brain functions. Overall, although results clearly suggest the validity of HBO 
therapy for the treatment of TBI, the underlying mechanism still needs to be studied in depth.
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